A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...

Immune cells in glioblastoma use fructose to evade immune response, pointing to a new treatment target. Northwestern Medicine ...

Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize ...

Cancer immunotherapy has transformed the treatment landscape for multiple malignancies; however, its clinical efficacy remains limited in many tumors due to ...

The inflammatory tumor microenvironment (TME) is a complex network of cancer, immune, and stromal cells interacting through cytokines and growth factors to drive tumor growth, angiogenesis, and immune ...

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and ...

The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and other cellular components. Certain elements of the TME can benefit patients ...

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR) in Lisbon, it is worth highlighting ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...

New research shows how cancer cells use a vitamin B7-dependent pathway to survive in the absence of glutamine, revealing potential drug targets.

Nutrition is increasingly recognized as a modifiable factor influencing the risk, progression, and survivorship of cancers that disproportionately affect ...

Severe COVID-19 and influenza infections can epigenetically reprogram lung and immune cells, creating a pro‑tumor environment that increases lung cancer risk, but vaccines may prevent this.